Clinical Trial Update: Safety and Immunogenicity of a Self-Amplifying RNA Vaccine Against Crimean-Congo Hemorrhagic Fever [Phase 1]

View source ↗

Summary

This clinical trial registry entry describes a Phase 1 study evaluating the safety and immunogenicity of a self-amplifying RNA vaccine targeting Crimean-Congo h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crimean-congo Hemorrhagic Fever

Drugs mentioned

• Self-amplifying RNA vaccine against Crimean-Congo hemorrhagic fever

Snippet

Sponsor: HDT Bio | Conditions: Vaccine, Crimean-Congo Hemorrhagic Fever | Phase 1 | Status: RECRUITING